With organic revenue this financial year expected to be around $280mil and the loan book growing over 25% per annum that means 2024 organic revenue will be around $350mil plus $20mil each for the NZ and UK acquisitions. So just short of $400mil for 2024 with corresponding growth in profits.
This is a great growth story and yet the SP is languishing. The overhang of unwanted shares is killing this stock.
Ann: Q3 FY 2023 Unaudited Trading Update, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CCV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
-0.005(2.27%) |
Mkt cap ! $134.9M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.0¢ | 21.5¢ | $12.58K | 57.30K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 206083 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 1067707 | 14 |
View Market Depth
| Last trade - 15.32pm 22/08/2024 (20 minute delay) ? |
| CCV (ASX) Chart |